AM-PHARMA
DEAD

Serial Number

79311483

Owner

AM-Pharma B.V.

Attorney

James C. Watson

Filing Date

Jan 28, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AM-PHARMA Trademark

Serial Number: 79311483

AM-PHARMA is a trademark filed by AM-Pharma B.V. on January 28, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

AM-Pharma B.V. (5 trademarks)

Stadsplateau 6
NL-3521 AZ Utrecht , NL

Entity Type: 16

Trademark Details

Filing Date

January 28, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical, medical and veterinary preparations for the treatment and prevention of kidney diseases and kidney dysfunction; plasters for medical purposes, adhesive bandages; disinfectants; dietary supplements for medical purposes; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of kidney disease and kidney dysfunction; pharmaceutical drugs for the treatment of kidney diseases and kidney dysfunction; pharmaceutical preparations to treat kidney diseases and kidney dysfunction

Provision of short-term care medical services in intensive care units and hospitals; services of hygiene and beauty care for people; consultancy and information related to short-term care biopharmaceutical products provided in intensive care units and hospitals; short-term care pharmaceutical consultancy provided in intensive care units and hospitals; provision of news and information in the field of short-term care medicines provided in intensive care units and hospitals; medical services for diagnosis of diseases of the human body provided in intensive care units and hospitals

Scientific and technological services, as well as research and design related thereto , in the field of kidney disease and kidney dysfunction; research in the scientific, technological and industrial fields in the field of kidney disease and kidney dysfunction; industrial analysis and industrial research services in the field of kidney disease and kidney dysfunction; development of technologies, diagnostics, drugs, personal care products, and devices for others in the field of kidney disease and kidney dysfunction; biotechnological research in the field of enzymatic synthesis; testing, authentication and quality control; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; pharmaceutical research; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical development of drugs; testing of pharmaceutical products; pharmaceutical drug development services; consulting in the field of pharmaceutical research; clinical research and research in the medical field relating to kidney disease and kidney dysfunction; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for others in the field of pharmaceutical products for the treatment of kidney disease and kidney dysfunction

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jan 19, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 19, 2024 FICR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 19, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 19, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 19, 2023 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 14, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 26, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 26, 2022 OPNR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 7, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2022 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 11, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 10, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 17, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 20, 2021 REPR